Search results for "time factor"

showing 10 items of 3219 documents

Tolerance of Volume Control Noninvasive Ventilation in Subjects With Amyotrophic Lateral Sclerosis.

2015

BACKGROUND: Noninvasive ventilation (NIV) tolerance has been identified as an independent predictor of survival in amyotrophic lateral sclerosis (ALS). Volume control continuous mandatory ventilation (VC-CMV) NIV has been associated with poor tolerance. The aim of this study was to determine the tolerance of subjects with ALS to VC-CMV NIV. METHODS: This was a prospective study involving subjects with ALS who were treated with VC-CMV NIV. Respiratory and functional parameters were recorded when the subjects began ventilatory support. NIV tolerance was evaluated after 3 months. RESULTS: Eighty-seven subjects with ALS were included. After 3 months, 80 subjects (92%) remained tolerant of NIV. …

Pulmonary and Respiratory MedicineMaleNeuromuscular diseaseTime FactorsPeak Expiratory Flow RateCritical Care and Intensive Care MedicineVolume controlContinuous mandatory ventilationForced Expiratory VolumemedicineHumansProspective StudiesRespiratory systemAmyotrophic lateral sclerosisProspective cohort studyAgedNoninvasive Ventilationbusiness.industryAmyotrophic Lateral SclerosisGeneral MedicineMiddle Agedmedicine.diseaseRespiratory failureCoughAnesthesiaNoninvasive ventilationFemalebusinessRespiratory InsufficiencyRespiratory care
researchProduct

External reinforcement of varicose veins with PTFE prosthesis in infrainguinal bypass surgery -- clinical results.

2003

OBJECTIVE Segmental varicose degeneration of the autogenous greater saphenous vein may limit its use in infrainguinal bypass surgery. Wrapping a PTFE prosthesis around dilated veins has emerged as an option to create externally reinforced vein bypasses. Results regarding graft patency and limb salvage were analyzed. METHODS Between September 1995 and January 2001, 35 infrainguinal bypass operations in 33 patients were performed with greater saphenous veins exhibiting segmental varicose dilatation. Grafts were followed by duplex scan and retrospective analysis of graft patency and limb salvage was performed. RESULTS One bypass prompted successful revision for early occlusion. Four bypasses r…

Pulmonary and Respiratory MedicineMaleReoperationmedicine.medical_specialtyTime FactorsPopliteal VeinLimb salvagemedicine.medical_treatmentInfrainguinal bypassGreater saphenous veinInguinal CanalProsthesisSeverity of Illness IndexTimeVaricose VeinsBlood Vessel Prosthesis ImplantationCoated Materials BiocompatibleOcclusionVaricose veinsMedicineHumansSaphenous VeinVeinPolytetrafluoroethyleneVascular PatencyAgedRetrospective StudiesAged 80 and overbusiness.industryGraft Occlusion VascularMiddle Agedmedicine.diseaseCombined Modality TherapySurvival AnalysisSurgeryRadiographyStenosismedicine.anatomical_structureTreatment OutcomeSurgeryFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesThe Thoracic and cardiovascular surgeon
researchProduct

Safety of tiotropium/olodaterol in chronic obstructive pulmonary disease: pooled analysis of three large, 52-week, randomized clinical trials.

2018

Abstract Background An extensive clinical trial program supports the efficacy and safety of tiotropium/olodaterol in chronic obstructive pulmonary disease (COPD). We examined the safety of tiotropium/olodaterol compared with tiotropium in a large population of patients, focusing on cardiovascular and respiratory events. Methods Patients (n = 9942) who received once-daily tiotropium/olodaterol 5/5 μg or tiotropium 5 μg (via Respimat®) in TONADO 1 & 2 and DYNAGITO were included. The number of patients and exposure-adjusted rate of events are presented for adverse events (AEs), serious AEs (SAEs), AEs leading to discontinuation, and cardiovascular and respiratory events. Findings Fewer patient…

Pulmonary and Respiratory MedicineMaleRiskmedicine.medical_specialtyTime FactorsRate ratiolaw.invention03 medical and health scienceschemistry.chemical_compoundPulmonary Disease Chronic Obstructive0302 clinical medicineRandomized controlled triallawCentral Nervous System DiseasesRisk FactorsInternal medicinemedicineHumans030212 general & internal medicineTiotropium BromideAdverse effectRandomized Controlled Trials as TopicCOPDbusiness.industryIncidenceOlodaterolmedicine.diseasehumanitiesrespiratory tract diseasesDiscontinuationBenzoxazinesClinical trialDrug Combinations030228 respiratory systemchemistryCardiovascular DiseasesFemaleSafetybusinesshuman activitiesMaceRespiratory medicine
researchProduct

Regulation of endothelial nitric oxide synthase (eNOS) in myocardium subjected to cardioplegic arrest.

2009

BACKGROUND: Nitric oxide (NO) production by both coronary endothelial cells and cardiomyocytes is thought to play a significant role in myocardial pathophysiology following ischemia/reperfusion (I/R). METHODS: In thirteen pigs subjected to 1 hour cardioplegic arrest (CA) on CPB, left ventricular (LV) biopsies were collected prior to CPB (baseline), at 60 min CPA, at 15 and 30 min reperfusion on CPB, and at 120 min post CPB. LV specimens were immunocytochemically stained against phospho-eNOS Ser1177 , phospho-eNOS Thr495 , phosphorylated ERK1/2, and AKT/PKB. Four additional pigs without CA served as controls. Cardiomyocytes were quantitatively investigated using TV densitometry (gray units: …

Pulmonary and Respiratory MedicineMaleThreoninemedicine.medical_specialtyTime FactorsNitric Oxide Synthase Type IIISwineHeart VentriclesIschemiaEnos phosphorylationVentricular Function LeftNitric oxidechemistry.chemical_compoundEnosInternal medicinemedicineSerineAnimalsPhosphorylationProtein kinase BMitogen-Activated Protein Kinase 1Cardiopulmonary BypassMitogen-Activated Protein Kinase 3Endothelial nitric oxide synthasebiologybusiness.industryMyocardiummedicine.diseasebiology.organism_classificationImmunohistochemistryMyocardial ContractionPathophysiologyEnzyme ActivationEndocrinologychemistryModels AnimalCardiologyHeart Arrest InducedPhosphorylationSurgeryFemaleCardiology and Cardiovascular MedicinebusinessProto-Oncogene Proteins c-aktThe Thoracic and cardiovascular surgeon
researchProduct

Impact of video-assisted thoracic surgery approach on postoperative mortality after lobectomy in octogenarians.

2019

The number of octogenarians who present with localized lung cancer eligible for surgical resection is increasing. Video-assisted thoracic surgery lobectomy has been widely accepted, but the potential benefit in octogenarians is not well established, especially for postoperative mortality. This study aimed to assess the impact of a video-assisted thoracic surgery approach on postoperative mortality after lobectomy for lung cancer in octogenarians.From January 2005 to December 2016, all patients aged more than 80 years who received lobectomy treatment for lung cancer were retrieved from the French Administrative Database. The end point was 30-day postoperative death. A propensity score was ge…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyLung NeoplasmsTime FactorsDatabases Factualmedicine.medical_treatment[SDV]Life Sciences [q-bio]030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineRisk FactorsThoracoscopyMedicineHumansThoracotomyLung cancerPneumonectomyComputingMilieux_MISCELLANEOUSAged 80 and overmedicine.diagnostic_testbusiness.industryThoracic Surgery Video-AssistedAge FactorsOdds ratiomedicine.diseaseConfidence intervalSurgeryTreatment Outcome030228 respiratory systemThoracotomyCardiothoracic surgeryPostoperative mortalityPropensity score matchingSurgeryFemaleFranceCardiology and Cardiovascular MedicinebusinessThe Journal of thoracic and cardiovascular surgery
researchProduct

Change from Hybrid to Fully Minimally Invasive and Robotic Esophagectomy is Possible without Compromises.

2018

Background The incidence of esophageal carcinoma is increasing in the western world, and esophageal resection is the essential therapy. Several studies report advantages of minimally invasive esophagectomies (MIEs) versus conventional open procedures (OPs). The benefits of the use of fully MIE or robot-assisted MIE (RAMIE) compared with the hybrid approaches (laparoscopic gastric preparation and open transthoracic esophagectomy) remain unclear. Methods Between July 2015 and August 2017, the data of 75 patients with esophageal carcinoma were prospectively registered. Of the 75 patients, 25 treated with a hybrid MIE (hybrid), 25 with total MIE (MIE), and 25 with RAMIE. All patients were oper…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyTime FactorsEsophageal Neoplasmsmedicine.medical_treatmentAnastomosislaw.invention03 medical and health sciences0302 clinical medicinePostoperative ComplicationsRobotic Surgical ProcedureslawRisk FactorsCarcinomaMedicineHumansThoracotomyAgedbusiness.industryMortality rateIncidence (epidemiology)ThoracoscopyLength of StayMiddle Agedmedicine.diseaseIntensive care unitSurgeryEsophagectomyPneumoniaTreatment OutcomeThoracotomyEsophagectomy030220 oncology & carcinogenesis030211 gastroenterology & hepatologySurgeryFemaleLaparoscopyClinical CompetenceCardiology and Cardiovascular MedicinebusinessLearning CurveThe Thoracic and cardiovascular surgeon
researchProduct

Strategies for endovascular aortic repair in aortobronchial and aortoesophageal fistulas.

2013

Objective To report our experience of thoracic endovascular aortic repair (TEVAR) for acute bleeding originating from the thoracic aorta in patients with aortobronchial fistula (ABF) or aortoesophageal fistula (AEF). Patients and Methods A total of nine patients (three woman) were treated from September 1995 to March 2012 by TEVAR for ABF (n = 5) and AEF (n = 4). The implants (N = 14) were introduced with fluoroscopic guidance via the aorta (n = 1), the iliac (n = 2), or femoral (n = 11) artery, respectively. Results All aortic lesions could be sealed successfully. Perioperative morbidity was 0% in the ABF group and 50% (2 of 4) in the AEF group and no procedure-related morbidity was noted …

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyTime FactorsFistulaAortic DiseasesAorta ThoracicHemorrhageRadiography InterventionalAortographyBlood Vessel Prosthesis ImplantationEsophageal Fistulamedicine.arteryMedicineThoracic aortaHumansAgedAged 80 and overVascular FistulaAortamedicine.diagnostic_testbusiness.industryEndovascular ProceduresAngiography Digital SubtractionPerioperativeMiddle Agedmedicine.diseaseMediastinitisSurgeryTreatment OutcomeCardiothoracic surgeryDescending aortaFluoroscopyAngiographySurgeryFemaleRadiologyBronchial FistulaCardiology and Cardiovascular MedicinebusinessTomography Spiral ComputedThe Thoracic and cardiovascular surgeon
researchProduct

Effects Of Whole Body Vibration In Patients With Chronic Obstructive Pulmonary Disease - A Randomized Controlled Trial

2012

Summary Introduction To date endurance and strength training are established and evidence-based exercise methods in patients with chronic obstructive pulmonary disease (COPD). There is an unmet need for further research in new and complementary exercise modalities. Additional whole body vibration training during pulmonary rehabilitation may be such a new approach that has not yet been investigated in patients with COPD. Methods Eighty-two patients (65 ± 9 yrs, FEV 1 pred. 38 ± 11%, female 51%) with COPD in GOLD stage III to IV assessed for a 3-week inpatient multidisciplinary rehabilitation program were on top randomly assigned to one of two intervention groups: (1) 3 × 3 min of bilateral d…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyTime FactorsStrength trainingmedicine.medical_treatmentSquatWalkingVibrationlaw.inventionPulmonary Disease Chronic ObstructiveRandomized controlled trialQuality of lifelawTrainingHumansMedicineWhole body vibrationIn patientPulmonary rehabilitationProspective StudiesProspective cohort studyExercisePhysical Therapy ModalitiesAgedCOPDExercise Tolerancebusiness.industryChronic obstructive pulmonary diseaseMinimal clinically important differencemedicine.diseaseRespiratory MusclesExercise TherapyRespiratory Function TestsPulmonary rehabilitationTreatment OutcomePhysical therapyFemalebusinessWhole body vibrationA107. ASSESSMENT, EXERCISE TRAINING AND OUTCOMES
researchProduct

Community-Acquired Pneumonia Patients at Risk for Early and Long-term Cardiovascular Events Are Identified by Cardiac Biomarkers.

2019

Background Community-acquired pneumonia (CAP) increases the risk of cardiovascular complications during and following the episode. The goal of this study was to determine the usefulness of cardiovascular and inflammatory biomarkers for assessing the risk of early (within 30 days) or long-term (1-year follow-up) cardiovascular events. Methods A total of 730 hospitalized patients with CAP were prospectively followed up during 1 year. Cardiovascular (proadrenomedullin [proADM], pro-B-type natriuretic peptide (proBNP), proendothelin-1, and troponin T) and inflammatory (interleukin 6 [IL-6], C-reactive protein, and procalcitonin) biomarkers were measured on day 1, at day 4/5, and at day 30. Resu…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyTime Factorsmedicine.drug_classCritical Care and Intensive Care MedicineRisk AssessmentProcalcitonin03 medical and health sciences0302 clinical medicineCommunity-acquired pneumoniaInternal medicineNatriuretic peptidePneumonia BacterialMedicineHumans030212 general & internal medicineMyocardial infarctionProspective StudiesAgedAged 80 and overbiologyTroponin Tbusiness.industryC-reactive proteinMiddle Agedmedicine.diseaseTroponinCommunity-Acquired InfectionsPneumonia030228 respiratory systemCardiovascular Diseasesbiology.proteinCardiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersChest
researchProduct

Chronological expression of Ciliated Bronchial Epithelium 1 during pulmonary development

2009

Ciliated Bronchial Epithelium (CBE) 1 is a novel gene, which is expressed in ciliated cells. As cilia are important during embryogenesis, the present authors characterised the murine homologue of CBE1 (Cbe1) and compared its temporal expression during murine and human lung development. Cbe1 cDNA was cloned and characterised using sequencing, standard PCR and Western blotting. Mouse and human embryonic/fetal lungs (HELs) were harvested for mRNA analysis and protein localisation in vivo and in vitro using RT-PCR and immunohistochemistry. The Cbe1 amino acid sequence was >75% identical with CBE1 and its alternative splicing and tissue distribution were highly conserved. Pulmonary expression of…

Pulmonary and Respiratory MedicinePathologymedicine.medical_specialtyDNA ComplementaryTime FactorsBlotting WesternDNA Mutational AnalysisBiologyTransfectionStatistics NonparametricImmunoenzyme TechniquesMiceOpen Reading FramesCiliogenesisGene expressionmedicineAnimalsHumansAmino Acid SequenceRNA MessengerCloning MolecularLungDNA PrimersFetusMessenger RNALungReverse Transcriptase Polymerase Chain ReactionEmbryogenesisAlternative splicingNuclear ProteinsCell DifferentiationMolecular biologyEpitheliumDNA-Binding Proteinsmedicine.anatomical_structureBronchial epithelium Asthma DevelopmentTranscription FactorsEuropean Respiratory Journal
researchProduct